Zenith Capital Corporation

Equities

ZENI.P

CA98936P1071

Biotechnology & Medical Research

Market Closed - Toronto S.E. Other stock markets 16:00:00 16/04/2024 BST			5-day change	1st Jan Change
0.105 ^CAD	-.--%		-.--%	-.--%

06-21	Zenith Capital Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024	CI
03-28	Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	CI

Zenith Capital Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024

June 21, 2024 at 01:21 am

Zenith Capital Corporation reported earnings results for the third quarter and nine months ended April 30, 2024. For the third quarter, the company reported net loss was CAD 0.054267 million compared to CAD 0.103283 million a year ago.
For the nine months, net loss was CAD 0.154688 million compared to CAD 0.166806 million a year ago.

Latest news about Zenith Capital Corporation

Zenith Capital Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024	06-21	CI
Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	03-28	CI
Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2023	11-27	CI
Zenith Capital Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	14/06/23	CI
Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	28/03/23	CI
Grand Samsara Consulting LLC and CBGB Ventures Corp. signed a binding letter agreement to acquire Zenith Capital Corporation (TSXV:ZENI.P) in a reverse merger transaction.	19/03/23	CI
Zenith Capital Corporation announced that it expects to receive CAD 1 million in funding from Grand Samsara Consulting LLC	07/03/23	CI
Zenith Capital Corporation announced that it has received CAD 0.2 million in funding	22/02/23	CI
Zenith Capital Corporation announced that it expects to receive CAD 0.2 million in funding	14/02/23	CI
Venda Robotix Ltd cancelled the acquisition of Zenith Capital Corporation (TSXV:ZENI.P) in a reverse merger transaction..	22/01/23	CI
Zenith Capital Corporation Reports Earnings Results for the First Quarter Ended October 31, 2022	08/12/22	CI
Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2022	16/11/22	CI
Zenith Capital Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	21/06/22	CI
Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022	28/03/22	CI
Zenith Capital Corporation Reports Earnings Results for the First Quarter Ended October 31, 2021	29/11/21	CI
Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2021	08/11/21	CI
Zenith Capital Corporation Auditor Raises 'Going Concern' Doubt	07/11/21	CI
Venda Robotix Ltd entered into a binding letter of intent to acquire Zenith Capital Corporation (TSXV:ZENI.P) in a reverse merger transaction.	17/08/21	CI
Zenith Capital Corporation Reports Earnings Results for the Third Quarter Ended April 30, 2021	02/06/21	CI
Zenith Capital Corporation Reports Earnings Results for the Second Quarter Ended January 31, 2021	05/03/21	CI
Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2020	15/10/20	CI
Zenith Capital Corporation Auditor Raises 'Going Concern' Doubt	14/10/20	CI
Zenith Capital Corporation announced that it has received $2.000001 million in funding	15/06/20	CI
Zenith Capital Corporation Reports Earnings Results for the Third Quarter Ended April 30, 2020	08/06/20	CI
Zenith Capital Corporation Reports Earnings Results for the Second Quarter Ended January 31, 2020	10/03/20	CI

Chart Zenith Capital Corporation

Duration

Period

More charts

Company Profile

Zenith Capital Corporation is a Canada-based capital pool company. The principal activity of the Company is the identification and evaluation of assets or a business and, once identified or evaluated, to negotiate an acquisition of, or participation in, a business subject to receipt of shareholders approval, if required, and acceptance by regulatory authorities (the Qualifying Transaction). The Company has not identified a business or asset that warrants acquisition or participation.

Sector

Biotechnology & Medical Research

Calendar

04/12/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
ZENITH CAPITAL CORPORATION	-.--%	325K
MODERNA, INC.	+16.59%	44.44B
IQVIA HOLDINGS INC.	-10.62%	37.68B
LONZA GROUP AG	+40.49%	39.84B
ALNYLAM PHARMACEUTICALS, INC.	+29.92%	31.46B
CELLTRION, INC.	-9.78%	27.02B
ICON PUBLIC LIMITED COMPANY	+12.34%	26.29B
UNITED THERAPEUTICS CORPORATION	+41.53%	13.8B
MEDPACE HOLDINGS, INC.	+31.49%	12.46B
BIO-TECHNE CORPORATION	-7.40%	11.26B

Other Biotechnology & Medical Research